TNYA Tenaya Therapeutics Inc
Company Analysis
Latest News
🟢 Tenaya Therapeutics is trading 5% up today with no confirmed catalyst
Tenaya Therapeutics is trading 5.13% higher at $0.62 now, with no company-specific reason identified for the session’s move. - No company-specific...
🟢 Tenaya Therapeutics is trading 9.59% up in pre-market on September 30, 2026; catalyst remains unclear
Tenaya Therapeutics is trading at $0.65, up 9.59%, in pre-market on September 30, 2026; the catalyst remains unclear. - No company-specific announcement dated...
🔴 Tenaya Therapeutics is trading 5% down today amid Iran-related inflation concerns
Tenaya Therapeutics is trading 5.36% down at $0.58 amid broader market pressure; no clear company-specific announcement explaining the September 28 decline...
🔴 Tenaya Therapeutics is trading 5% down today as Treasury yields reached post-2007 highs
Tenaya Therapeutics is trading at $0.63, down 5.29% on September 24, 2026, with the decline appearing tied primarily to biotech-sector weakness and broader...
🟢 Tenaya Therapeutics is trading 5% up today amid broader biotechnology strength
Tenaya Therapeutics is trading 5.16% up now at $0.71, outperforming the prior close of $0.67 amid broader biotechnology strength. - XBI was up 2.55% during...
🟢 Tenaya Therapeutics is trading 10.68% up in pre-market — no clear company-specific catalyst identified
Tenaya Therapeutics is trading 10.68% up in pre-market at $0.76, up from the September 1, 2026 close of $0.69; no clear catalyst identified. - No...
🟢 Tenaya Therapeutics is trading 7.58% up in pre-market after Nvidia’s earnings beat strengthened risk appetite
Tenaya Therapeutics is trading 7.58% up now at $0.75 amid broader risk-on sentiment; no new company-specific announcement was identified for August 27,...
🔴 Tenaya Therapeutics is trading 5.4% down today — No clear company-specific catalyst reported
Tenaya Therapeutics is trading 5.4% down at $0.66 versus its August 21, 2026 close of $0.70, with no clear company-specific catalyst identified. - No clearly...
🔴 Tenaya Therapeutics is trading 6.4% down today
Tenaya Therapeutics is trading 6.4% down now at $0.68, with no fresh company-specific announcement found to explain the decline. - Shares fell from the August...
🔴 Tenaya Therapeutics is trading 5.7% down today after Q2 revenue miss and larger-than-expected loss
Tenaya Therapeutics is trading 5.7% down at $0.74 after its August 5, 2026, second-quarter results missed revenue and loss expectations. - Collaboration...
Tenaya Therapeutics' second quarter loss widens on impairment charge, missing estimates, but provides positive clinical updates.
Tenaya Therapeutics reported second quarter collaboration revenue of $1.11 million and a net loss of $0.20 per share, missing consensus estimates of $10.0...
🟢 Tenaya Therapeutics is trading 5% up today ahead of its Q2 earnings report
Tenaya Therapeutics is trading 5% up at $0.76 as investors position ahead of its Q2 2026 earnings report. • The company is scheduled to release its quarterly...
Tenaya Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Tenaya Therapeutics Inc is expected to report a Q2 2026 consensus loss of $0.08 per share on revenue of $10.0 million, with its current stock price of $0.75...
🔴 Tenaya Therapeutics is trading 5.3% down today on Nasdaq listing pressure and dilution concerns
Tenaya Therapeutics is trading 5.3% down today at $0.79 as investors react to ongoing Nasdaq minimum bid price non-compliance and recent dilution from a $60...
🔴 Tenaya Therapeutics is trading 5.8% down today amid biotech weakness and sector-wide profit-taking
Tenaya Therapeutics is trading at $0.82 (-5.78%) as the stock moves lower alongside a weaker biotech tape and broader risk-off sentiment. • The decline...
🔴 Tenaya Therapeutics is trading 8.1% down today amid broader market weakness and speculative volatility
Tenaya Therapeutics is trading at $0.80 (-8.05%) in pre-market, reflecting normal volatility for a speculative biotech stock following a volatile run in early...
🔴 Tenaya Therapeutics is trading 6.5% down today, extending a multi-day pullback
Tenaya Therapeutics is trading at $0.80 (down 6.5%), extending a multi-day pullback following a volatile rally earlier in July. • The decline appears to be...
🟢 Tenaya Therapeutics is trading 5.8% up today, rebounding from a recent pullback
Tenaya Therapeutics is trading 5.8% up today at $0.93, rebounding from yesterday’s pullback and continuing its recent volatile pattern. • The move occurs...
🔴 TNYA is trading 5.1% down today amid broader market weakness and profit-taking
TNYA is trading at $0.87 (-5.09%) today, appearing to give back gains from a previous rebound amid broader market weakness and a lack of fresh company-specific...
🟢 TNYA is trading 6.1% up today as it extends recent positive momentum
TNYA is trading at $0.92 (6.1% up) as it extends a short-term uptrend despite a lack of fresh company-specific news or analyst actions today. • The move...